Ioflupane - brand name or equal
Ended Awarded Last action
- Contract number
- 36C24425N0377
- Awardee
-
Jubilant Draximage Radiopharmacies, Inc. UEI ZL79MXYVNDM1
- Awarding agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $125,400
Award facts
- Contract value 100% obligated
- $125,400.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Aspinwall, PA 15215, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$6,600 | |
| Original award | $132,000 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 4 (VISN 4), awarded a $125.4K firm fixed-price blanket purchase agreement call to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on January 17, 2025, for the supply of Ioflupane radiopharmaceutical products. The contract carries an ultimate completion date of January 16, 2026, with performance taking place in Aspinwall, Pennsylvania. No set-aside designation was used in this award. Jubilant Radiopharma, a for-profit small disadvantaged business headquartered in Norcross, Georgia, specializes in manufacturing and distributing radiopharmaceuticals and nuclear medicine products essential to VA healthcare operations, serving as a critical supplier of medical isotopes and diagnostic imaging agents across the VA's nationwide network.
This delivery order operates under Jubilant Radiopharma's larger blanket purchase agreement vehicle with VISN 4, reflecting the VA's ongoing reliance on the company's specialized capabilities in radiopharmaceutical supply. The company maintains an extensive portfolio of indefinite delivery contracts and blanket purchase agreements across multiple VISNs, with individual vehicle ceiling values ranging from $220K to $39.8M and completion dates extending through 2030. Ioflupane is a dopamine transporter imaging agent used in nuclear medicine diagnostic procedures, and this award ensures continued access to this specialized product for veterans receiving diagnostic imaging services at VA facilities within VISN 4's service area.
Quick answers
Who was awarded contract 36C24425N0377?
36C24425N0377 was awarded to Jubilant Draximage Radiopharmacies, Inc. by Veterans Integrated Service Network 4 (Veterans Health Administration) on January 17, 2025.
How much is contract 36C24425N0377 worth?
The government has obligated $125,400 on 36C24425N0377.
Is contract 36C24425N0377 an order under another contract?
Yes. 36C24425N0377 is a BPA call under 36C24425A0011, a blanket purchase agreement.
Was contract 36C24425N0377 competed?
The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award